Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Alsa Ventures I Scsp investment portfolio

Alsa Ventures I Scsp has made numerous investments in companies such as Axovia Therapeutics, Vantage Biosciences, and Epsilogen within the Healthcare & Life Sciences sector.

vc
Portfolio
3
Team
0

Portfolio (3)

CompanySectorCitySourceLast confirmed on
Axovia Therapeutics Ltd
Axovia Therapeutics Ltd develops gene‑therapy treatments for ciliopathies, with its lead program AXV101—a AAV9‑based therapy aimed at halting retinal degeneration in Bardet‑Biedl Syndrome patients carrying BBS1 mutations. The company targets rare‑disease patients requiring novel genetic interventions for retinal dystrophy.
Healthcare & Life SciencesLondonConfirmed2026-03-07
Epsilogen Ltd
Epsilogen develops immunoglobulin E (IgE) antibody therapeutics for the treatment of cancer, targeting oncology patients.
Healthcare & Life SciencesLondonConfirmed2025-07-25

Sign up to see the full portfolio

+1 more company

Sign up

Shareholding changes (6)

Alsa Ventures I Scsp's positions across portfolio companies
2026

Sign up free to see when this investor has bought or sold shares.

+4 more changes

Sign up

Articles (1)